Brentuximab;Brentuximab Vedotin;Anti-CLDN18.2;Anti NS1 of dengue virus;Moxetumomab;Research Grade Brentuximab(DHD80901);Adcetris;cAC10-vcMMAE
用途
Brentuximab vedotin is an antibody-drug conjugate (ADC) used for targeting CD30-positive malignancies, such as Hodgkin lymphoma and systemic anaplastic large cell lymphoma, by delivering the cytotoxic agent monomethyl auristatin E (MMAE) specifically to CD30-expressing tumor cells.